GPC
NEO icon

Glacier Peak Capital’s NeoGenomics NEO Stock Holding History

Glacier Peak Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-172,953
Closed -$991K – 69
2015
Q3 		$991K Buy
172,953
+51,167
+42% +$317K 0.55% 44
2015
Q2 		$659K Buy
+121,786
New +$628K 0.33% 57

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Glacier Peak Capital's NEO Position: Q4 2015 in Review

Glacier Peak Capital sold out of NeoGenomics (NEO) in Q4 2015, closing a stake of 172,953 shares — an estimated $991K sold.

Glacier Peak Capital first reported a position in NEO in Q2 2015 and held it in 2 quarters. The position peaked at $991K in Q3 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q4 2015.

  • Glacier Peak Capital reported no remaining NeoGenomics position as of Q4 2015 after selling out during the quarter.
  • Glacier Peak Capital sold 172,953 NeoGenomics shares in Q4 2015, an estimated $991K.
  • Glacier Peak Capital first reported a position in NeoGenomics in Q2 2015 and held it in 2 quarters.
  • Glacier Peak Capital's NeoGenomics position peaked at $991K in Q3 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2015.

Based on Glacier Peak Capital's 13F filing for Q4 2015, filed 9 Feb 2016.